An Interview with Dr. Anne Hellebust, Director of Product
An Interview with Dr. Anne Hellebust, Director of Product.
An Interview with Dr. Anne Hellebust, Director of Product Read More »
News
RNAscope common questions, troubleshooting, and tips and tricks
When performing RNAscope image analysis, you can set yourself up for success with a combination of thoughtful experimental design, rigorous assay execution and validation. At Indica Labs, the most common challenges we see in RNAscope image analysis include chromogenic staining that has saturated to black, which causes color deconvolution challenges, loss of nuclear morphology due to over-digestion of tissue, and failing to verify and validate an image analysis solution before scaling up.
RNAscope common questions, troubleshooting, and tips and tricks Read More »
Press Release: Indica Labs’ HALO AP® platform achieves CE-IVD certification for use in primary diagnosis
Albuquerque, NM, 10 January, 2022 – Indica Labs, a leading provider of computational pathology software and services, is proud to announce that following ISO13485 certification, HALO AP® has received a CE Mark for use in primary diagnosis within the European Economic Area, Switzerland, and the UK.
Bridge the Gap with Indica Labs’ Pharma Services
At Indica Labs, our Pharma Services team is here to help you extract more data from your biomarker assays with our digital image analysis services. From single biomarker IHC to ISH/FISH and highly multiplexed fluorescence and imaging mass cytometry, we offer quantitative image analysis solutions with our own HALO and HALO AI analysis platforms. With over 150 completed image analysis projects, our team has experience across multiple disease areas, applications, and assay types, including immune phenotyping in tumors, biomarker expression profiling across TMAs and whole slide tissues, pharmacodynamic assays, target validation studies, and more. In addition to leveraging our own image analysis and image management solutions, we utilize the in-house expertise of our image analysts and algorithm development teams to enable you to make the right decisions about your biomarker program.
Bridge the Gap with Indica Labs’ Pharma Services Read More »
An Interview with Vlado Ovtcharov, Senior Research Scientist – Artificial Intelligence
Expansive Interview Vlado Ovtcharov: Senior Research Scientist – Artificial Intelligence
An Interview with Vlado Ovtcharov, Senior Research Scientist – Artificial Intelligence Read More »
2021: A Year in Review at Indica Labs
As 2021 draws to a close, the team at Indica Labs would like to take this opportunity to reflect on the year and to thank our customers for their continued support through this second pandemic year. Despite the ongoing challenges that the pandemic presents, we celebrate the achievements of our customers who have published over 250 publications in peer-reviewed journals this year with an impressive average impact factor of 9.12. To learn more about these publications spanning immuno-oncology, oncology, immunology, infectious disease, and neurology, read our high-impact publications guide and visit our Literature page.
2021: A Year in Review at Indica Labs Read More »
Tumor-specific tumor-resident cytotoxic T cells predict recurrence in stage III melanoma patients treated with adjuvant immunotherapy
20 January 2022 | In this 60-minute webinar, learn how HALO and HALO AI collaborate to perform tissue and cell segmentation, quantification of T-cell subsets in tumor regions, and spatial analysis .
A Deep Learning Convolutional Neural Network Can Differentiate Between Helicobacter Pylori Gastritis and Autoimmune Gastritis with Results Comparable to Gastrointestinal Pathologists
13 January 2022 | In this 60-minute webinar, researchers and pathologists from the University of New Mexico will discuss their recently published study using the HALO AI deep learning convolutional neural network (CNN) to determine whether a CNN can differentiate autoimmune gastritis from Helicobacter pylori gastritis.
2021 Masterclass: HALO AI Deep Dive on the Validation Workflow
16 December 2021 | In this Masterclass webinar we will delve into one of the latest AI tools, the AI validation workflow (available as of the HALO v3.3 release). This tool can be used to answer the question How good is my trained AI network?
2021 Masterclass: HALO AI Deep Dive on the Validation Workflow Read More »
Bench-to-Bedside Transition of Novel HALO® Assays into Clinical Trials with HALO AP®
10 December 2021 | In this 1-hour webinar, featured speakers will demonstrate end-to-end how to develop a quantitative assay in HALO and transition it into clinical trials using HALO AP.
Bench-to-Bedside Transition of Novel HALO® Assays into Clinical Trials with HALO AP® Read More »